Gestational Metabolic Abnormalities and Maternal and Infant Nutrition and Health
NCT01405547
Body Weight, Diabetes Mellitus
Toronto, Ontario, Canada
View Trial DetailsNCT Number: NCT03301519
This is a family based genotype-phenotype study designed to assess genetic and environmental influences on obesity, insulin resistance and beta cell function in the context of gestational diabetes.
Looking for future studies?
Notify Me8 year and older
All sexes
Observational
Mexican American women with prior gestational diabetes and their first degree relatives and Mexican American women with prior normal glucose tolerance in pregnancy are studied with detailed phenotyping consisting of oral and intravenous glucose tolerance tests, body composition studies, diet and physical activity assessments, and circulating biomarkers potentially related to obesity, insulin resistance, pancreatic beta cell function, gestational diabetes and type 2 diabetes. Spouses of the gestational diabetic and control probands are studied with oral glucose tolerance tests. Offspring of the gestational and control probands have fasting glucose determinations. All participants provide DNA for genetics testing. A subset of the gestational diabetic probands and their first degree relatives return 3-5 years after baseline testing for repeat phenotyping.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Single time point for primary cohort, repeated 4.5 years later in subset
Disposition index from intravenous glucose tolerance test
Time frame: Single time point for primary cohort, repeated 4.5 years later in subset
Si from computer modeled intravenous glucose tolerance test
Time frame: Single time point for primary cohort, repeated 4.5 years later in subset
Incremental area under insulin curve during first 10 minutes intravenous glucose tolerance test
Time frame: Single time point for primary cohort, repeated 4.5 years later in subset
normal, impaired or diabetic glucose level determined using American Diabetes Associate criteria applied to glucose levels from a 2-hour, 75 gram oral glucose tolerance test
Time frame: Single time point for primary cohort, repeated 4.5 years later in subset
Fasting glucose >125 mg/dl and/or 2-hour glucose on 75 gram oral glucose tolerance test >199 mg/dl
Time frame: Single time point for primary cohort, repeated 4.5 years later in subset
Measured by semi-quantitative Harvard Food Frequency Questionnaire
Time frame: Single time point for primary cohort, repeated 4.5 years later in subset
Measured by Multi-ethnic Cohort Physical Activity Questionnaire
Time frame: Single time point for primary cohort, repeated 4.5 years later in subset
Percent body fat measured by dual photon X-ray absorptiometry
Time frame: Single time point for primary cohort, repeated 4.5 years later in subset
Fasting levels of approximately 20 adipocytokines
University of Southern California
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01405547
Body Weight, Diabetes Mellitus
Toronto, Ontario, Canada
View Trial DetailsNCT02218931
Body Weight, Cardiovascular Diseases
London, United Kingdom
View Trial DetailsNCT00486629
Behavior, Body Weight
Winnipeg, Manitoba, Canada
View Trial DetailsNCT03750695
Behavior, Body Weight
St Louis, Missouri, United States
View Trial Details